Fine-mapping prioritized three credible causal genes (TSPAN14, FAM180B, and GOLGA6L9), which were selected in the credible set the most times in AD and cognition-related phenotypes (Supplementary Table S13). This evidence concerns the gene TSPAN14 and Alzheimer disease.